SpringerLink
Log in

Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions

  • Images in Hematology
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. van Gammeren AJ, Alcala LS, Smolders M, Boersma RS. Numerous Russell bodies and Dutcher bodies in multiple myeloma. Br J Haematol. 2015;170:743.

    Article  PubMed  Google Scholar 

  2. Gu X, Barrios R, Cartwright J, Font RL, Truong L, Herrera GA. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy. Hum Pathol. 2003;34:270–7.

    Article  CAS  PubMed  Google Scholar 

  3. Gabriel L, Escribano L, Perales J, Bellas C, Odriozola J, Navarro JL. Multiple myeloma with crystalline inclusions in most hemopoietic cells. Am J Hematol. 1985;18:405–11.

    Article  CAS  PubMed  Google Scholar 

  4. Hristov AC, Saladino A, Nava VE, Gocke CD. Auer rod-like inclusions in a low-grade B-cell leukemia. Ann Diagn Pathol. 2010;14:292–5.

    Article  PubMed  Google Scholar 

  5. Matoso A, Rizack T, Treaba DO. Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature. Diagn Pathol. 2010;5:6.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Nakamine H, Nishihara T, Saito K, Takenaka T, Maeda J. Needle-shaped inclusions in plasma cells in a patient with hypogammaglobulinemia. Am J Clin Pathol. 1982;78:549–55.

    Article  CAS  PubMed  Google Scholar 

  7. Henon P, Leclerc JP, Marsan C, Gerota I, Ortin DM, Sauvegrain JC. Plasma-cells crystal-like inclusions two cases of monoclonal gammapathy (author’s transl). Arch Anat Cytol Pathol. 1976;24:379–83.

    CAS  PubMed  Google Scholar 

  8. Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, et al. Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. Blood. 2008;111:86–93.

    Article  CAS  PubMed  Google Scholar 

  9. Harada H, Watanabe M, Suzuki K, Yanagita S, Suzuki T, Yoshida Y, et al. Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality. Int J Hematol. 2009;90:353–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Gifu Prefectural Medical Center, Gifu, Japan

    Toshiki Yamada

  2. First Department of Internal Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan

    Yasuhito Nannya, Masahito Shimizu & Hisashi Tsurumi

  3. Department of Transfusion Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

    Yasuhito Nannya & Mitsuru Seishima

  4. Department of Gastroenterology, Gifu Prefectural Medical Center, Gifu, Japan

    Naoki Mita

  5. Department of Informative Clinical Medicine, Gifu University Graduate School of Medicine, Gifu, Japan

    Mitsuru Seishima

Authors
  1. Toshiki Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuhito Nannya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naoki Mita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masahito Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mitsuru Seishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hisashi Tsurumi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hisashi Tsurumi.

Ethics declarations

Conflict of interest

Dr. Yamada reports personal fees from Bristol-Myers Squibb, Novartis, Asahi Kasei Pharma, Celgene, Nihon Shinyaku, Kyowa Hakko Kirin, Chugai Pharmaceutical, Eisai, Ono pharmaceutical, Astellas Pharma, Alexion Pharmaceutical, Mochida Pharmaceutical, Sumitomo Dainippon Pharma, GlaxoSmithKline, outside the submitted work; Dr. Nannya reports personal fees from Bristol-Myers Squibb, Novartis, Takeda Pharmaceutical, Asahi Kasei Pharma, Otsuka Pharmaceutical, Yakult, Wako Jyunyaku Kogyo, Celgene, Pfizer, Otsuka Pharmaceutical Factory, Nihon Shinyaku, Kyowa Hakko Kirin, Eisai, McCann Healthcare Communications, Ono pharmaceutical, Astellas Pharma, Chugai Pharmaceutical, personal fees from Bristol-Myers Squibb, outside the submitted work; Dr. Mita has nothing to disclose. Dr. Shimizu has nothing to disclose. Dr. Seishima has nothing to disclose. Dr. Tsurumi reports personal fees from Bristol-Myers Squibb, Novartis, Chugai Pharmaceutical, Takeda Pharmaceutical, Asahi Kasei Pharma, Otsuka Pharmaceutical, Celgene, Pfizer, Nihon Shinyaku, Kyowa Hakko Kirin, Eisai, Astellas Pharma, Dai-Nippon Sumitomo Pharma, MSD, Mochida-Seiyaku, Janssen Pharmaceutical, Glaxo SmithKline, Dai-ichi Sankyo, Meiji Seika, Chugai pharmaceutical, Shire, ViiV healthcare, outside the submitted work.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, T., Nannya, Y., Mita, N. et al. Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions. Int J Hematol 103, 483–485 (2016). https://doi.org/10.1007/s12185-016-1985-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-016-1985-3

Keywords

Search

Navigation